Eversept Partners, LP
- SEC CIK
- 0001697013
- 最新申報
- 2026/8/14
2024 年第 2 季持倉
持倉截至 2024/6/30，2024/8/14 申報。只含多頭部位，變化是跟 2024 年第 1 季比股數。
- 持股檔數
- 72
- 較 2024 年第 1 季 +4
- 總值
- $13.1 億
- 較 2024 年第 1 季 −$3,141 萬 (−2.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GSKGSK plc | ADR | 3,468,080 | $1.34 億 | 10.2% | −303,914−8.1% | 減碼 | 歷史 |
| NTRANatera, Inc. | COM | 1,173,494 | $1.27 億 | 9.7% | −604,557−34.0% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 1,155,588 | $7,742 萬 | 5.9% | +1,155,588 | 新進 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 4,720,460 | $7,671 萬 | 5.9% | −1,304,709−21.7% | 減碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 235,351 | $7,497 萬 | 5.7% | −15,784−6.3% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 3,613,631 | $7,419 萬 | 5.7% | +480,518+15.3% | 加碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 2,043,214 | $7,392 萬 | 5.7% | +219,433+12.0% | 加碼 | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 533,011 | $7,133 萬 | 5.5% | +112,312+26.7% | 加碼 | 歷史 |
| RVTYRevvity, Inc. | COM | 451,582 | $4,735 萬 | 3.6% | −31,578−6.5% | 減碼 | 歷史 |
| HCAHCA Healthcare, Inc. | COM | 135,480 | $4,353 萬 | 3.3% | +31,659+30.5% | 加碼 | 歷史 |
| TECHBIO-TECHNE Corp | COM | 543,044 | $3,891 萬 | 3.0% | −64,643−10.6% | 減碼 | 歷史 |
| HQYHealthequity, Inc. | COM | 413,531 | $3,565 萬 | 2.7% | −7,814−1.9% | 減碼 | 歷史 |
| CYHCommunity Health Systems Inc | COM | 8,037,470 | $2,701 萬 | 2.1% | +56,829+0.7% | 加碼 | 歷史 |
| RGENRepligen Corp | COM | 194,291 | $2,449 萬 | 1.9% | +186,054+2,258.8% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 633,015 | $2,343 萬 | 1.8% | −78,100−11.0% | 減碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 456,881 | $2,177 萬 | 1.7% | +80,443+21.4% | 加碼 | 歷史 |
| NVONovo Nordisk A S | ADR | 146,956 | $2,098 萬 | 1.6% | +84,612+135.7% | 加碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 21,233 | $1,922 萬 | 1.5% | +8,356+64.9% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 505,836 | $1,753 萬 | 1.3% | +94,358+22.9% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 34,593 | $1,488 萬 | 1.1% | −19,925−36.5% | 減碼 | 歷史 |
| HUMHumana Inc | Stock | 38,023 | $1,421 萬 | 1.1% | +2,491+7.0% | 加碼 | 歷史 |
| VTRSViatris Inc | Stock | 1,329,282 | $1,413 萬 | 1.1% | +12,813+1.0% | 加碼 | 歷史 |
| ZIMVZimVie Inc. | Stock | 767,659 | $1,401 萬 | 1.1% | +203,161+36.0% | 加碼 | 歷史 |
| MNKDMannkind Corp | COM NEW | 2,256,952 | $1,178 萬 | 0.9% | −134,176−5.6% | 減碼 | 歷史 |
| BKDBrookdale Senior Living Inc. | COM | 1,546,842 | $1,056 萬 | 0.8% | +228,077+17.3% | 加碼 | 歷史 |
| DHRDanaher Corp | Stock | 40,855 | $1,021 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 100,000 | $927.1 萬 | 0.7% | +100,000 | 新進 | – |
| TVTXTravere Therapeutics, Inc. | COM | 1,091,165 | $896.9 萬 | 0.7% | +135,547+14.2% | 加碼 | 歷史 |
| ELVElevance Health, Inc. | Stock | 14,657 | $794.2 萬 | 0.6% | +264+1.8% | 加碼 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 837,847 | $779.2 萬 | 0.6% | +837,847 | 新進 | 歷史 |
| CNCCentene Corp | Stock | 115,820 | $767.9 萬 | 0.6% | +23,034+24.8% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 567,487 | $738.3 萬 | 0.6% | +425,412+299.4% | 加碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 138,489 | $734.1 萬 | 0.6% | +115,671+506.9% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 96,089 | $725.6 萬 | 0.6% | −101,242−51.3% | 減碼 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 1,152,573 | $712.3 萬 | 0.5% | −279,854−19.5% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 126,877 | $687.4 萬 | 0.5% | +126,877 | 新進 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 329,890 | $633.7 萬 | 0.5% | −24,075−6.8% | 減碼 | 歷史 |
| EOLSEvolus, Inc. | COM | 574,462 | $623.3 萬 | 0.5% | +574,462 | 新進 | 歷史 |
| MOHMolina Healthcare, Inc. | COM | 18,277 | $543.4 萬 | 0.4% | +12,449+213.6% | 加碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 1,739,129 | $509.6 萬 | 0.4% | +647,710+59.3% | 加碼 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 5,484,148 | $494.1 萬 | 0.4% | −510,324−8.5% | 減碼 | 歷史 |
| OSCROscar Health, Inc. | CL A | 310,893 | $491.8 萬 | 0.4% | +310,893 | 新進 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 110,010 | $449.8 萬 | 0.3% | +110,010 | 新進 | 歷史 |
| LQDALiquidia Corp | COM NEW | 373,554 | $448.3 萬 | 0.3% | −22,633−5.7% | 減碼 | 歷史 |
| MYGNMyriad Genetics Inc | COM | 181,961 | $445.1 萬 | 0.3% | +181,961 | 新進 | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 1,328,454 | $433.1 萬 | 0.3% | −98,043−6.9% | 減碼 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 4,987,180 | $432.7 萬 | 0.3% | −29,140−0.6% | 減碼 | 歷史 |
| TSVT2seventy bio, Inc. | COMMON STOCK | 1,107,743 | $426.5 萬 | 0.3% | −69,935−5.9% | 減碼 | 歷史 |
| NVRONevro Corp | COM | 499,395 | $420.5 萬 | 0.3% | +109,732+28.2% | 加碼 | 歷史 |
| ICLRIcon PLC | COM | 12,642 | $396.3 萬 | 0.3% | −2,705−17.6% | 減碼 | 歷史 |
| MRUSMerus N.V. | COM | 66,474 | $393.3 萬 | 0.3% | −53,008−44.4% | 減碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 71,596 | $314.8 萬 | 0.2% | +71,596 | 新進 | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 4,308,527 | $296.4 萬 | 0.2% | −1,904,221−30.7% | 減碼 | 歷史 |
| GHGuardant Health, Inc. | COM | 99,377 | $287.0 萬 | 0.2% | −350,209−77.9% | 減碼 | 歷史 |
| IFRXInflaRx N.V. | COM | 1,566,930 | $272.6 萬 | 0.2% | +261,790+20.1% | 加碼 | 歷史 |
| AVTRAvantor, Inc. | COM | 125,394 | $265.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 204,781 | $263.3 萬 | 0.2% | +204,781 | 新進 | 歷史 |
| IQVIQVIA Holdings Inc. | Stock | 12,178 | $257.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ALECAlector, Inc. | COM | 541,739 | $245.9 萬 | 0.2% | +5,568+1.0% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 92,909 | $245.3 萬 | 0.2% | −162,617−63.6% | 減碼 | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 91,907 | $217.7 萬 | 0.2% | −5,158−5.3% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 610,902 | $212.6 萬 | 0.2% | +610,902 | 新進 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 286,266 | $194.9 萬 | 0.1% | +3,232+1.1% | 加碼 | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 496,171 | $178.6 萬 | 0.1% | +496,171 | 新進 | 歷史 |
| KURAKura Oncology, Inc. | COM | 72,317 | $148.9 萬 | 0.1% | +72,317 | 新進 | 歷史 |
| ABSIAbsci Corp | COM | 325,509 | $100.3 萬 | 0.1% | +325,509 | 新進 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 152,965 | $94.8 萬 | 0.1% | +152,965 | 新進 | 歷史 |
| Affimed N VN01045207 | ORDINARY SHS NEW | 166,460 | $90.7 萬 | 0.1% | 00.0% | 不變 | – |
| STOKStoke Therapeutics, Inc. | COM | 61,277 | $82.8 萬 | 0.1% | −228,723−78.9% | 減碼 | 歷史 |
| GTHXG1 Therapeutics, Inc. | COM | 199,963 | $45.6 萬 | <0.1% | +199,963 | 新進 | 歷史 |
| ACIUAC Immune SA | SHS | 99,313 | $39.6 萬 | <0.1% | −25,276−20.3% | 減碼 | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 418,208 | $30.3 萬 | <0.1% | −970,736−69.9% | 減碼 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | $1.37 億 | – |
| SPYSPDR S&P 500 ETF Trust | ETF | $1,676 萬 | – |
2024 年第 1 季之後清倉（12 檔）
2024 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 1 季股數 | 2024 年第 1 季市值 | 2024 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| PFEPfizer Inc | Stock | 1,102,042 | $3,058 萬 | 2.3% | 歷史 |
| SWAVShockwave Medical, Inc. | COM | 80,555 | $2,623 萬 | 2.0% | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 175,631 | $1,846 萬 | 1.4% | 歷史 |
| Taro Pharmaceutical Inds LtdM8737E108 | SHS | 263,541 | $1,116 萬 | 0.8% | – |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 2,325,591 | $667.4 萬 | 0.5% | 歷史 |
| WATWaters Corp | COM | 13,628 | $469.1 萬 | 0.4% | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 88,934 | $349.0 萬 | 0.3% | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 18,557 | $330.2 萬 | 0.2% | 歷史 |
| Morphosys AG617760202 | SPONSORED ADS | 165,924 | $301.0 萬 | 0.2% | – |
| JBIOJade Biosciences, Inc. | COM | 54,150 | $160.1 萬 | 0.1% | 歷史 |
| Curevac N VN2451R105 | COM | 515,691 | $156.3 萬 | 0.1% | – |
| VINCVincerx Pharma, Inc. | COM NEW | 79,588 | $40.3 萬 | <0.1% | 歷史 |